⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
Next Generation Drug Conjugates (NDCs) Market worth $42.55 billion by 2035 | MarketsandMarkets™
prnewswire.com
ALNY
GILD
IONQ
ABBV
ARWR
The Rise of 6 Emerging Therapies in a Critical Spinal Cord Injury Market Void | DelveInsight
globenewswire.com
ABBV
Throat Cancer Market Trends and Breakthroughs Through 2026-2030 & 2035 Driven by Precision Oncology
globenewswire.com
PFE
MRK
ABBV
INO
CHRS
Tumor Microenvironment Market to Reach Over $2.7 Billion by 2030 - Rising Demand for Personalized Oncology Therapies and Next-Gen Immunotherapies Driving the Industry
globenewswire.com
PFE
JNJ
MRK
ABBV
CHRS
AbbVie IBD Scholarship Program Marks 15 Years: Applications Open for 2026
globenewswire.com
ABBV
Glioblastoma Multiforme Market Intelligence Report 2026-2030 & 2035: Advanced Targeted Drugs Propel Industry Growth
globenewswire.com
PFE
ABBV
BMY
AZN
MRK
Gliosarcoma Market Intelligence Report 2026-2030 & 2035: Expansion of Molecular Testing and Increased Research Funding is Driving Industry Growth
globenewswire.com
NVCR
MRK
PFE
ABBV
Mission BioCapital Announces Opening of $4 Million 2026 Platinum Program Contest and 2025 Platinum Ticket Investments
prnewswire.com
ABBV
LLY
Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035 - United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate
globenewswire.com
UTHR
PFE
AMGN
JNJ
ABBV
MRK
BMY
MAC
FORE Biotherapeutics Receives Breakthrough Therapy Designation for Plixorafenib
businesswire.com
ABBV
MRK